Towards an individualised target concentration of adalimumab in rheumatoid arthritis

Ann Rheum Dis. 2014 Jul;73(7):1428-9. doi: 10.1136/annrheumdis-2013-204971. Epub 2014 Feb 18.
No abstract available

Keywords: Anti-TNF; Pharmacokinetics; Rheumatoid Arthritis.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal, Humanized / blood*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Antirheumatic Agents / blood*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / drug therapy
  • Dose-Response Relationship, Drug
  • Humans
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab